Illumina Inc. stock outperforms competitors on strong trading day
Shares of Illumina Inc. ILMN rose 2.33% to $86.62 Friday, on what proved to be an all-around positive trading session for the ...
MarketWatch21d
Illumina Inc. stock underperforms Wednesday when compared to competitors
Shares of Illumina Inc. ILMN slipped 1.79% to $94.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market ... which the company reached on November 5th.
Investing7d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Competitive Landscape: Illumina faces increasing competition from companies like Pacific Biosciences ... appears on our undervalued or overvalued stock lists. These tools provide a clearer ...
Investor's Business Daily on MSN15d
Illumina Stock Slammed As China Retaliates Against Trump's Tariffs
Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.
Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN stock.
Investing7d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Competitive Landscape: Illumina faces increasing competition from companies like Pacific Biosciences (NASDAQ ... You can also see if ILMN appears on our undervalued or overvalued stock lists. These ...